SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024505
Filing Date
2021-05-06
Accepted
2021-05-06 07:08:46
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fulc-10q_20210331.htm 10-Q 2361980
2 EX-10.1 fulc-ex101_59.htm EX-10.1 190727
3 EX-10.2 fulc-ex102_57.htm EX-10.2 195630
4 EX-10.3 fulc-ex103_58.htm EX-10.3 142569
5 EX-10.4 fulc-ex104_56.htm EX-10.4 202765
6 EX-31.1 fulc-ex311_6.htm EX-31.1 11861
7 EX-31.2 fulc-ex312_11.htm EX-31.2 12703
8 EX-32.1 fulc-ex321_10.htm EX-32.1 6258
9 EX-32.2 fulc-ex322_7.htm EX-32.2 6208
  Complete submission text file 0001564590-21-024505.txt   7804856

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT fulc-20210331.xml EX-101.INS 1366424
11 XBRL TAXONOMY EXTENSION SCHEMA fulc-20210331.xsd EX-101.SCH 52986
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fulc-20210331_cal.xml EX-101.CAL 49210
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fulc-20210331_def.xml EX-101.DEF 173976
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE fulc-20210331_lab.xml EX-101.LAB 393031
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fulc-20210331_pre.xml EX-101.PRE 313901
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38978 | Film No.: 21895740
SIC: 2834 Pharmaceutical Preparations